229 related articles for article (PubMed ID: 22089773)
1. The effect of L-carnitine supplementation on lipid parameters, inflammatory and nutritional markers in maintenance hemodialysis patients.
Suchitra MM; Ashalatha VL; Sailaja E; Rao AM; Reddy VS; Bitla AR; Sivakumar V; Rao PV
Saudi J Kidney Dis Transpl; 2011 Nov; 22(6):1155-9. PubMed ID: 22089773
[TBL] [Abstract][Full Text] [Related]
2. Dramatic decrease of carnitine esters after interruption of exogenous carnitine supply in hemodialysis patients.
Bene J; Csiky B; Wittmann I; Sulyok E; Melegh B
Ren Fail; 2012; 34(5):555-8. PubMed ID: 22417076
[TBL] [Abstract][Full Text] [Related]
3. Oral carnitine supplementation for dyslipidemia in chronic hemodialysis patients.
Naini AE; Sadeghi M; Mortazavi M; Moghadasi M; Harandi AA
Saudi J Kidney Dis Transpl; 2012 May; 23(3):484-8. PubMed ID: 22569432
[TBL] [Abstract][Full Text] [Related]
4. Effects of L-carnitine infusions on inflammatory and nutritional markers in haemodialysis patients.
Duranay M; Akay H; Yilmaz FM; Senes M; Tekeli N; Yücel D
Nephrol Dial Transplant; 2006 Nov; 21(11):3211-4. PubMed ID: 16861734
[TBL] [Abstract][Full Text] [Related]
5. Effect of intradialytic intravenous administration of omega-3 fatty acids on nutritional status and inflammatory response in hemodialysis patients: a pilot study.
Szklarek-Kubicka M; Fijałkowska-Morawska J; Zaremba-Drobnik D; Uciński A; Czekalski S; Nowicki M
J Ren Nutr; 2009 Nov; 19(6):487-93. PubMed ID: 19616450
[TBL] [Abstract][Full Text] [Related]
6. Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients.
Rasic-Milutinovic Z; Perunicic G; Pljesa S; Gluvic Z; Sobajic S; Djuric I; Ristic D
Ren Fail; 2007; 29(3):321-9. PubMed ID: 17497447
[TBL] [Abstract][Full Text] [Related]
7. Effects of unsaturated fat dietary supplements on blood lipids, and on markers of malnutrition and inflammation in hemodialysis patients.
Ewers B; Riserus U; Marckmann P
J Ren Nutr; 2009 Sep; 19(5):401-11. PubMed ID: 19541503
[TBL] [Abstract][Full Text] [Related]
8. The Unexpected Effects of L-Carnitine Supplementation on Lipid Metabolism in Hemodialysis Patients.
Katalinic L; Krtalic B; Jelakovic B; Basic-Jukic N
Kidney Blood Press Res; 2018; 43(4):1113-1120. PubMed ID: 30016788
[TBL] [Abstract][Full Text] [Related]
9. The effect of long-term intravenous high dose B-complex vitamins with or without folic acid on serum homocysteine in hemodialysis patients.
Sombolos K; Fragia T; Natse T; Bartholomatos G; Karagianni A; Katsaris G; Christidou F; Bamichas G; Stangou M; Papagalanis N
J Nephrol; 2002; 15(6):671-5. PubMed ID: 12495282
[TBL] [Abstract][Full Text] [Related]
10. The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients.
Chevalier CA; Liepa G; Murphy MD; Suneson J; Vanbeber AD; Gorman MA; Cochran C
J Ren Nutr; 2002 Jul; 12(3):183-9. PubMed ID: 12105816
[TBL] [Abstract][Full Text] [Related]
11. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
[TBL] [Abstract][Full Text] [Related]
12. Effect of dialysate composition on the lipid response to L-carnitine supplementation.
Zilleruelo G; Novak M; Hsia SL; Goldberg R; Abitbol C; Monkus E; Strauss J
Kidney Int Suppl; 1989 Nov; 27():S259-63. PubMed ID: 2699997
[TBL] [Abstract][Full Text] [Related]
13. Effects of L-carnitine supplement on serum inflammatory cytokines, C-reactive protein, lipoprotein (a), and oxidative stress in hemodialysis patients with Lp (a) hyperlipoproteinemia.
Shakeri A; Tabibi H; Hedayati M
Hemodial Int; 2010 Oct; 14(4):498-504. PubMed ID: 20812958
[TBL] [Abstract][Full Text] [Related]
14. [L-carnitine in peritoneal dialysis].
De Vecchi AF; Arduini A; Di Liberato L; Bonomini M
G Ital Nefrol; 2011; 28(4):393-400. PubMed ID: 21809308
[TBL] [Abstract][Full Text] [Related]
15. Omega-3 fatty acids supplementation does not affect serum lipids in chronic hemodialysis patients.
Poulia KA; Panagiotakos DB; Tourlede E; Rezou A; Stamatiadis D; Boletis J; Zampelas A
J Ren Nutr; 2011 Nov; 21(6):479-84. PubMed ID: 21439849
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
[TBL] [Abstract][Full Text] [Related]
17. The role of oral L-carnitine therapy in chronic hemodialysis patients.
Sabry AA
Saudi J Kidney Dis Transpl; 2010 May; 21(3):454-9. PubMed ID: 20427868
[TBL] [Abstract][Full Text] [Related]
18. [Effect of L-carnitine supplementation on lipid metabolism of renal failure, dialysis-dependent children and adolescents].
Böhles H; Michalk D; von Wendt-Göknur E
Infusionstherapie; 1991 Oct; 18(5):224-6. PubMed ID: 1769735
[TBL] [Abstract][Full Text] [Related]
19. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
[TBL] [Abstract][Full Text] [Related]
20. Effects of zinc supplementation on serum zinc and C-reactive protein concentrations in hemodialysis patients.
Rashidi AA; Salehi M; Piroozmand A; Sagheb MM
J Ren Nutr; 2009 Nov; 19(6):475-8. PubMed ID: 19541504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
